
Sign up to save your podcasts
Or


In this Review Series episode, Associate Editor Dr. Philippe Armand speaks with multiple authors about what it might look like to improve treatments follicular lymphoma, a disease that has been put on the backburner of innovation due to its generally treatable nature. Dr. Armand discusses "Treatment of relapsed and refractory follicular lymphoma: which treatment for which patient for which line of therapy?" with author Dr. Carla Casulo, "The future of follicular lymphoma management: strategies on the horizon” with author Dr. Sarah C. Rutherford, and "An updated understanding of follicular lymphoma transformation” with Dr. Erin M. Parry.
Find the whole review series on follicular lymphoma in volume 146 issue 15 of Blood Journal.
By American Society of Hematology4.1
4949 ratings
In this Review Series episode, Associate Editor Dr. Philippe Armand speaks with multiple authors about what it might look like to improve treatments follicular lymphoma, a disease that has been put on the backburner of innovation due to its generally treatable nature. Dr. Armand discusses "Treatment of relapsed and refractory follicular lymphoma: which treatment for which patient for which line of therapy?" with author Dr. Carla Casulo, "The future of follicular lymphoma management: strategies on the horizon” with author Dr. Sarah C. Rutherford, and "An updated understanding of follicular lymphoma transformation” with Dr. Erin M. Parry.
Find the whole review series on follicular lymphoma in volume 146 issue 15 of Blood Journal.

11,159 Listeners

135 Listeners

325 Listeners

504 Listeners

76 Listeners

27 Listeners

1,143 Listeners

2 Listeners

365 Listeners

378 Listeners

1 Listeners

51 Listeners

197 Listeners

30 Listeners

5 Listeners